Home Overview Press Room Blog Publications For Students about us
Search

News Article

This scientist is trying to stop a lab-created global disasterby Kristen V. BrownFusionJune 27th, 2016"If we misuse our power, we lose the trust. That is the tightrope we walk," says Kevin Esvelt.
The Supreme Court decision that's shaking up biotechby Damian GardeSTATJune 27th, 2016A lower court's decision will stand: Sequenom can't patent its prenatal gene test because it is based on a natural biological process.
Eugenics victim still waiting for last paymentby Tim BucklandStar News OnlineJune 25th, 2016North Carolina's fund to compensate victims of its eugenic sterilization program is in limbo, with lawsuits pending.
What does Brexit mean for bioethics?by Xavier SymonsBioEdgeJune 25th, 2016The UK may not leave the Council of Europe, the umbrella organization for the Committee on Bioethics.
All about the base: New businesses eye the opportunities in managing genome dataThe EconomistJune 25th, 2016Currently, one firm - Illumina - controls 70% of a market worth $3.3 billion in 2015.
CRISPR Therapeutics adds $38M to Series B pot, but lags behind Parkerby Ben AdamsFierce BiotechJune 24th, 2016An NIH committee has backed a study funded by billionaire Sean Parker that will attempt to alter the T cells of 15 people with cancer.
Bill covering in vitro fertilization for injured veterans clears the House by Seattle Times StaffThe Seattle TimesJune 23rd, 2016Veterans Affairs is closer to paying for in vitro fertilization for injured soldiers seeking to have children.
As surrogacy industry expands, legal and ethical issues mulledby Bun Sengkong & Will JacksonThe Phnom Penh PostJune 23rd, 2016Surrogacy agencies in Cambodia and websites such as Gay with Kids facilitate cross-border surrogacy, although the Cambodian government remains unclear on surrogacy policies.
They’re going to CRISPR people. What could possibly go wrong?by Sharon BegleySTATJune 23rd, 2016Possible consequences range from off-target alterations to conflicts of interest in the clinical trial.
Stem Cell Scientist Suspected of Involuntary Manslaughterby Karl RitterABC NewsJune 22nd, 2016A disgraced stem cell scientist is facing preliminary charges of involuntary manslaughter in connection with two patients who died after windpipe transplants.
Displaying 1-10 of 4485  
Next >> 
Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1122 University Ave, Suite 100, Berkeley, CA 94702 • • (p) 1.510.665.7760 • (F) 1.510.665.8760